Partnering to combat disease, strengthen systems, and address emerging threats
In Senegal, political stability and economic growth have opened new doors for health and development. Yet the country still faces urgent gaps in care and services. Since 2001, PATH has collaborated with government leaders, communities, health care workers, and other stakeholders to respond.
Our broad portfolio includes a focus on malaria, strengthening health systems, epidemic preparedness, reproductive health, and noncommunicable diseases. Other efforts include testing and validating promising health products and exploring innovative approaches across nutrition, environment, and agriculture. Because Senegal is a hub for its region, many of our efforts also support countries throughout francophone Africa.
Our work in Senegal
Malaria: PATH is working with Senegal’s malaria control program to eliminate malaria nationwide. We equip health workers to prevent and ultimately eliminate malaria using proven approaches, including bednets, large-scale testing and treatment with antimalarial drugs, and community engagement. We also develop and deploy digital tools to improve data collection and use in Senegal, helping leaders identify and interrupt outbreaks quickly.
Strengthening health systems: Recognizing that strong health systems are the foundation of all care, we work with the Ministry of Health (MOH) and local leaders to close gaps and build capacity in such areas as disease surveillance, laboratory services, and immunization. These efforts improve care and equip Senegal to respond to future challenges.
Global health security: PATH is a partner in the Global Health Security Agenda, which is helping to strengthen the capacity of partner countries to prevent, detect, and respond to public health emergencies. We are supporting Senegal’s MOH to reduce the number and magnitude of infectious disease outbreaks by improving surveillance, strengthening the laboratory network, responding to antimicrobial resistance, and building health information and reporting systems.
Reproductive health: Our long-standing work to improve reproductive health in Senegal includes expanding the availability and use of the easy-to-use injectable contraceptive Sayana® Press; conducting research on self-injection of Sayana Press; evaluating vaccination against human papillomavirus (HPV), the primary cause of cervical cancer; and improving HPV screening and treatment. We also support the Forum for Contraceptive Security in Francophone Africa (Sécurité Contraceptive en Afrique Francophone or SECONAF), which mobilizes more than 190 organizations to improve contraceptive supply across French-speaking African countries.
Noncommunicable diseases (NCDs): Diabetes, cardiovascular disease, cancer, chronic lung diseases, and other NCDs are on the rise in Senegal. PATH is identifying gaps in the availability and affordability of essential supplies for NCDs; helping to improve diagnosis and management and add NCD care into standard services; and convening leaders to address this growing threat.
Advocacy: PATH also partners with advocates in Senegal to strengthen capacity and support for policies and investments that make women’s and children’s health a national priority.
Sayana Press is a registered trademark of Pfizer Inc.
Photo: PATH/Fatou Kande-Senghor.
The story of Sayana® Press
Global health security
Strengthening systems and innovating in digital health
An “all-in-one” injectable contraceptive increases access
Our goals, work, and impact in Senegal